3/6
09:00 am
zbh
Zimmer Biomet Holdings, Inc. Investigated by the Portnoy Law Firm
Low
Report
Zimmer Biomet Holdings, Inc. Investigated by the Portnoy Law Firm
3/6
09:00 am
zbh
Zimmer Biomet Holdings, Inc. Investigated by the Portnoy Law Firm
Low
Report
Zimmer Biomet Holdings, Inc. Investigated by the Portnoy Law Firm
3/6
09:00 am
zbh
Zimmer Biomet Holdings, Inc. Investigated by the Portnoy Law Firm
Low
Report
Zimmer Biomet Holdings, Inc. Investigated by the Portnoy Law Firm
2/25
11:15 am
zbh
What To Expect From Solventum's (SOLV) Q4 Earnings [Yahoo! Finance]
Low
Report
What To Expect From Solventum's (SOLV) Q4 Earnings [Yahoo! Finance]
2/25
07:32 am
zbh
Zimmer Biomet to Release New Data, Highlight Key Innovations at American Academy of Orthopaedic Surgeons Annual Meeting [Yahoo! Finance]
Low
Report
Zimmer Biomet to Release New Data, Highlight Key Innovations at American Academy of Orthopaedic Surgeons Annual Meeting [Yahoo! Finance]
2/25
07:06 am
zbh
Zimmer Biomet to Release New Data, Highlight Key Innovations at American Academy of Orthopaedic Surgeons Annual Meeting
Low
Report
Zimmer Biomet to Release New Data, Highlight Key Innovations at American Academy of Orthopaedic Surgeons Annual Meeting
2/23
07:00 am
zbh
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2026
Low
Report
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2026
2/20
07:18 am
zbh
Zimmer Biomet (NYSE:ZBH) is now covered by analysts at William Blair. They set a "market perform" rating on the stock.
Low
Report
Zimmer Biomet (NYSE:ZBH) is now covered by analysts at William Blair. They set a "market perform" rating on the stock.
2/18
09:05 am
zbh
ZBH Investor Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) Over Alleged Emerging Market Failures and "Inconsistent" Execution
Low
Report
ZBH Investor Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) Over Alleged Emerging Market Failures and "Inconsistent" Execution
2/14
01:32 am
zbh
2/12
09:02 am
zbh
Zimmer Biomet (NYSE:ZBH) had its "underweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
Zimmer Biomet (NYSE:ZBH) had its "underweight" rating reaffirmed by analysts at Barclays PLC.
2/11
12:50 pm
zbh
Zimmer Biomet (ZBH) Is Up 6.1% After Earnings Beat And New Buyback Plan Is Announced [Yahoo! Finance]
Low
Report
Zimmer Biomet (ZBH) Is Up 6.1% After Earnings Beat And New Buyback Plan Is Announced [Yahoo! Finance]
2/11
10:59 am
zbh
Zimmer Biomet (NYSE:ZBH) had its price target raised by analysts at Citigroup Inc. from $94.00 to $98.00. They now have a "neutral" rating on the stock.
Low
Report
Zimmer Biomet (NYSE:ZBH) had its price target raised by analysts at Citigroup Inc. from $94.00 to $98.00. They now have a "neutral" rating on the stock.
2/11
10:24 am
zbh
Zimmer Biomet (NYSE:ZBH) had its price target raised by analysts at Wells Fargo & Company from $93.00 to $98.00. They now have an "equal weight" rating on the stock.
Low
Report
Zimmer Biomet (NYSE:ZBH) had its price target raised by analysts at Wells Fargo & Company from $93.00 to $98.00. They now have an "equal weight" rating on the stock.
2/11
10:13 am
zbh
Zimmer Biomet (NYSE:ZBH) had its "sell" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Zimmer Biomet (NYSE:ZBH) had its "sell" rating reaffirmed by analysts at UBS Group AG.
2/11
07:06 am
zbh
Zimmer Biomet (NYSE:ZBH) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
Zimmer Biomet (NYSE:ZBH) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
2/10
01:32 pm
zbh
Zimmer Biomet (NYSE:ZBH) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $112.00 price target on the stock.
Low
Report
Zimmer Biomet (NYSE:ZBH) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $112.00 price target on the stock.
2/10
01:11 pm
zbh
Zimmer Biomet Holdings, Inc. (ZBH) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Zimmer Biomet Holdings, Inc. (ZBH) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/10
01:06 pm
zbh
Zimmer Biomet outlines 2026 revenue growth of 1%–3% amid U.S. sales force overhaul and innovation cycle [Seeking Alpha]
Low
Report
Zimmer Biomet outlines 2026 revenue growth of 1%–3% amid U.S. sales force overhaul and innovation cycle [Seeking Alpha]
2/10
01:06 pm
zbh
Zimmer Biomet reports 2025 revenue growth yet tempers 2026 outlook [Yahoo! Finance]
Low
Report
Zimmer Biomet reports 2025 revenue growth yet tempers 2026 outlook [Yahoo! Finance]
2/10
01:00 pm
zbh
Zimmer Biomet (NYSE:ZBH) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
Low
Report
Zimmer Biomet (NYSE:ZBH) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
2/10
10:33 am
zbh
Zimmer Biomet (ZBH) Q4 2025 Earnings Transcript [Yahoo! Finance]
Low
Report
Zimmer Biomet (ZBH) Q4 2025 Earnings Transcript [Yahoo! Finance]
2/10
09:43 am
zbh
Zimmer Biomet (ZBH) Q4 Earnings and Revenues Top Estimates [Yahoo! Finance]
Low
Report
Zimmer Biomet (ZBH) Q4 Earnings and Revenues Top Estimates [Yahoo! Finance]
2/10
08:31 am
zbh
Zimmer Biomet beats quarterly estimates on strong hips, knees device demand [Yahoo! Finance]
Low
Report
Zimmer Biomet beats quarterly estimates on strong hips, knees device demand [Yahoo! Finance]
2/10
07:52 am
zbh
Zimmer Biomet (NYSE:ZBH) Beats Q4 CY2025 Sales Expectations [Yahoo! Finance]
Low
Report
Zimmer Biomet (NYSE:ZBH) Beats Q4 CY2025 Sales Expectations [Yahoo! Finance]